Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Ablation Devices Market Forecast 2028 By Application (Cardiology, Oncology, Ophthalmology, Gynecology, Urology, Cosmetic Surgery), By Technology (Radiofrequency Devices, Laser/Light Ablation, Ultrasound Devices, Cryoablation Devices), By End-use (Hospitals, Ambulatory Surgical Centers), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: March 2022   |   Report ID: GR2086   |   Delivery: PDF  Request Free Sample

    North America Ablation Devices Market size crossed USD 3 billion in 2021 and is anticipated to expand at a CAGR of 10.9% CAGR from 2022 to 2028. The industry growth is primarily attributed to growing preference for minimally invasive procedures in the region. Additionally, numerous benefits offered by such minimally invasive procedures over open surgical procedure will positively influence the market growth. Furthermore, the rising prevalence of atrial fibrillation in the general population will increase the number of cardiac ablation procedures.

    North America Ablation Devices Market

    Get more details on this report - Request Free Sample PDF

    Rising prevalence of cancer and other chronic diseases across the region coupled with increasing healthcare expenditure will stimulate the market demand. Significant increase in number of cancer patients have been observed in North America where radiofrequency ablation devices are majorly use for treatment of cancer.

    North America Market, By Product

    North America Ablation Devices Market By Product

    Get more details on this report - Request Free Sample PDF

    The radiofrequency devices segment will showcase around 10.5% growth rate during the forecast period. Increasing use of devices in the field of oncology, cosmetology, cardiology, and others for effective treatment will augment demand for radiofrequency devices in the market. Additionally, various advantages associated with use of radiofrequency devices such as quick relief, high success rate in the treatment of atrial fibrillation will contribute to the market revenue.

    North America Market, By End-use

    The hospital’s segment held around 50% North America ablation devices market share in 2021, due to increasing prevalence of cardiac arrhythmia disorders globally coupled with increasing geriatric pool. Additionally, owing to various advantages such as availability of skilled workforce and presence of sophisticated healthcare infrastructure will further drive the market expansion. Furthermore, expanding number of hospitals and growing number of patient visits leading to high rate of treatment performed in hospital settings.

    North America Market, By Country

    U.S. ablation devices market revenue was more than USD 2.5 billion in 2021 and will grow at 10.9% CAGR through 2028. Rapid adoption of unhealthy lifestyle choices such as excessive tobacco consumption, alcohol drinking, and smoking are leading to an increasing prevalence of cardiovascular disorders. According to the CDC, every year in U.S., nearly 6.5 million deaths are reported due to cardiovascular diseases. Furthermore, rising awareness regarding cardiovascular diseases and availability of advanced treatment options will drive the market growth.

    Competitive Industry Landscape

    Some of the leading companies involved in the North America ablation devices market include Abbott Laboratories, AngioDynamics, Inc, AtriCure Inc, Biotronik SE & Co. KG, Bausch & Lomb Incorporated, Boston Scientific Corporation, CONMED Corporation, Medtronic plc, Elekta AB, Olympus Corporation, Varian, and Ethicon, Inc (Johnson & Johnson).

    These notable market players are undertaking several growth strategies to broaden market share through collaboration, acquisitions, and novel product launches. For instance, in January 2022, Abbott has received U.S. FDA clearance for its new cardiac mapping platform EnSite X EP System with EnSite Omnipolar Technology (OT). The device that helps physicians to treat abnormal heart rhythms, i.e., cardiac arrhythmias. This has helped company to expand its product offering in U.S. and across Europe and strengthen its position in the market.

    Frequently Asked Question(FAQ) :

    How big is North America ablation devices market?
    The market share for North America ablation devices was crossed $3 billion in 2021 and is expected to showcase 10.9% CAGR during the forecast timeline of 2022-2028.
    What factors will drive North America radiofrequency ablation devices industry forecast?
    North America market size from radiofrequency ablation devices may record around 10.5% CAGR through 2028 due to various benefits of using these devices, such as quick relief from pain and high success rate in treating atrial fibrillation.
    Why are hospitals across North America extensively adopting ablation devices?
    Hospitals captured around 50% share of the regional industry in 2021 due to rising cases of cardiac arrythmia along with the strong presence of sophisticated healthcare infrastructure and trained medical professionals.
    What makes the U.S. an attractive market for ablation devices?
    The market revenue for ablation devices in U.S. was surpassed $2.5 billion in 2021 and may record 10.9% CAGR through 2028 as the prevalence of cardiovascular disorders is increasing due to unhealthy lifestyle choices, such as excessive alcohol & tobacco consumption and smoking.
    Which are the companies operating in North America ablation devices landscape?
    AtriCure Inc, AngioDynamics, Inc, Biotronik SE & Co. KG, Abbott Laboratories, Boston Scientific Corporation, and Bausch & Lomb Incorporated, among many others, are the eminent participants of this industry.

    Get this research report on North America Ablation Devices Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]